Elanco appoints Robert VanHimbergen as CFO effective July 7, 2025

Elanco Animal Health Inc

Robert VanHimbergen appointed EVP and CFO, effective July 7, 2025; Todd Young stays as advisor through Aug 31, 2025.
VanHimbergen previously SVP and CFO of Hillenbrand; prior 15 years at Johnson Controls and PwC.
Base salary $660k, target annual cash incentive 75% of base, annual long-term incentive target $2.645M.
Make-whole awards: cash bonus $890k (3-year clawback) and RSU $1.735M (3-year ratable vesting).
Company reaffirmed Q2 and FY 2025 guidance issued May 7, 2025.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Robert VanHimbergen

Executive Vice President and Chief Financial Officer

ELAN · Elanco Animal Health Inc

Effective: 2025-07-07
Filed: May 28, 2025, 7:59 PM ET

the Company announced the appointment of Robert (Bob) VanHimbergen as Executive Vice President and Chief Financial Officer, effective July 7, 2025.

Role change

Todd Young

Chief Financial Officer

ELAN · Elanco Animal Health Inc

Effective: 2025-07-07
Successor: Robert VanHimbergen
Filed: May 28, 2025, 7:59 PM ET

Mr. VanHimbergen succeeds Todd Young who will continue to serve as an advisor, in a non-executive capacity, through August 31, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Robert VanHimbergen was appointed as Executive Vice President and Chief Financial Officer at Elanco Animal Health Inc.

Action: appointed
Role: Executive Vice President and Chief Financial Officer

Exact text from the filing

the Company announced the appointment of Robert (Bob) VanHimbergen as Executive Vice President and Chief Financial Officer, effective July 7, 2025.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Todd Young changed role as Chief Financial Officer at Elanco Animal Health Inc.

Action: succeeded
Role: Chief Financial Officer

Exact text from the filing

Mr. VanHimbergen succeeds Todd Young who will continue to serve as an advisor, in a non-executive capacity, through August 31, 2025.

View on SEC.gov

Elanco Animal Health Inc filing history →

Source: SEC EDGAR

accession 0001104659-25-053305

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.